Table of Contents Table of Contents
Previous Page  2417 / 2894 Next Page
Information
Show Menu
Previous Page 2417 / 2894 Next Page
Page Background

heparin response during cardiopulmonary bypass.

J Thorac Cardiovasc Surg 102:505, 1991.

256. Dietrich W, Barankay A, Hahnel C, Richter JA:

High-dose aprotinin in cardiac surgery: Three years’

experience in 1,784 patients. J Cardiothorac Vasc

Anesth 6:324, 1992.

257. Davies MJ, Allen A, Kort H, et al: Prospective, ran-

domized, double-blind study of high-dose aproti-

nin in pediatric cardiac operations. Ann Thorac

Surg 63:497, 1997.

258. Adatia I, Perry S, Moore P, et al: Inhaled nitric oxide

and hemodynamic evaluation of patients with pul-

monary hypertension before transplantation. J Am

Coll Cardiol 25:1652-1664, 1995.

259. Bellinger DC, Wypij D, du Plessis AJ, et al: Neuro-

developmental status at eight years in children with

dextro-transposition of the great arteries: The

Boston Circulatory Arrest Trial [see comment].

J Thorac Cardiovasc Surg 126:1385-1396, 2003.

260. Bellinger DC, Wypij D, Kuban KC, et al: Develop-

mental and neurological status of children at 4 years

of age after heart surgery with hypothermic circu-

latory arrest or low-flow cardiopulmonary bypass.

Circulation 100:526-532, 1999.

261. Bellinger DC, Rappaport LA, Wypij D, et al: Patterns

of developmental dysfunction after surgery during

infancy to correct transposition of the great arteries.

J Dev Behav Pediatr 18:75-83, 1997.

262. Bellinger DC, Jonas RA, Rappaport LA, et al: Deve-

lopmental and neurologic status of children after

heart surgery with hypothermic circulatory arrest

orlow-flowcardiopulmonarybypass[seecomment].

N Engl J Med 332:549-555, 1995.

263. Limperopoulos C, Majnemer A, Shevell MI, et al:

Predictors of developmental disabilities after open

heart surgery in young children with congenital

heart defects. J Pediatr 141:51-58, 2002.

264. Limperopoulos C, Majnemer A, Shevell MI, et al:

Functional limitations in young children with con-

genital heart defects after cardiac surgery. Pediatrics

108:1325-1331, 2001.

265. Limperopoulos C, Majnemer A, Rosenblatt B, et al:

Association between electroencephalographic fin-

dings and neurologic status in infants with conge-

nital heart defects. J Child Neurol 16:471-476,

2001.

266. Limperopoulos C, Majnemer A, Shevell MI, et al:

Neurodevelopmental status of newborns and

infants with congenital heart defects before and

after open heart surgery [see comment]. J Pediatr

137:638-645, 2000.

267. Mahle WT, Tavani F, Zimmerman RA, et al: An MRI

study of neurological injury before and after conge-

nital heart surgery. Circulation 106:I109-I114,

2002.

268. Galli KK, Zimmerman RA, Jarvik GP, et al: Periven-

tricular leukomalacia is common after neonatal

cardiac surgery. J Thorac Cardiovasc Surg 127:692-

704, 2004, [erratum appears in J Thorac Cardiovasc

Surg 128:498, 2004].

269. Balasubramanian SK, Tiruvoipati R, Amin M, et al:

Factors influencing the outcome of paediatric

cardiac surgical patients during extracorporeal cir-

culatory support. J Cardiothorac Surg 2:4, 2007.

270. Jaggers JJ, Forbess JM, Shah AS, et al: Extracorporeal

membrane oxygenation for infant postcardiotomy

support: Significance of shunt management. Ann

Thorac Surg 69:1476-1483, 2000.

271. Shah SA, Shankar V, Churchwell KB, et al: Clinical

outcomes of 84 children with congenital heart disease

managed with extracorporeal membrane oxygenation

after cardiac surgery. ASAIO J 51:504-507, 2005.

272. Stiller B, Lemmer J, Merkle F, et al: Consumption of

blood products during mechanical circulatory

support in children: Comparison between ECMO

and a pulsatile ventricular assist device. Intensive

Care Med 30:1814-1820, 2004.

273. Alsoufi B, Shen I, Karamlou T, et al: Extracorporeal

life support in neonates, infants, and children after

repair of congenital heart disease: Modern era

results in a single institution. Ann Thorac Surg

80:15-21, 2005.

274. Ibrahim AE, Duncan BW, Blume ED, Jonas RA:

Long-term follow-up of pediatric cardiac patients

requiring mechanical circulatory support. Ann

Thorac Surg 69:186-192, 2000.

275. Blume ED, Naftel DC, Bastardi HJ, et al: Outcomes

of children bridged to heart transplantation with

ventricular assist devices: A multi-institutional

study. Circulation 113:2313-2319, 2006.

276. Carberry KE, Gunter KS, Gemmato CJ, Morales

DLS: Mechanical circulatory support for the pedia-

tric patient. Crit Care Nurs Q 30:121-142, 2007.

277. Kolovos NS, Bratton SL, Moler FW, et al: Outcome

of pediatric patients treated with extracorporeal life

support after cardiac surgery. Ann Thorac Surg

76:1435-1442, 2003.

278. Duncan B, Hraska V, Jonas RA, et al: Mechanical

circulatory support in children with cardiac disease.

J Thorac Cardiovasc Surg 117:529-542, 1999.

279. Shen I, Giacomuzzi C, Ungerleider RM, et al:

Current strategies for optimizing the use of cardio-

pulmonary bypass in neonates and infants. Ann

Thorac Surg 75:S729-S734, 2003.

280. Heise D, Bräuer A, Quintel M: Recombinant activa-

ted facor VII (Novo 7) in patients with ventricular

assist devices: Case report and review of the current

literature. J Cardiothorac Surg 2:47, 2007.

281. Duncan B: Mechanical circulatory support for

infants and children with cardiac disease. Ann

Thorac Surg 73:1670-1677, 2002.

282. Hosenpud JD, Bennett LE, Berkeley M, et al: The

registry of the International Society for Heart and

Lung Transplantation: Fifteenth official report 1998.

J Heart Lung Transplant 17:656, 1998.

283. Kirklin JK, Naftel DC, McGiffin DC, et al: Analysis of

morbid events and risk factors for death after cardiac

transplantation. J Am Coll Cardiol 11:917, 1998.

284. Gajarski RJ, Towbin JA, Bricker JT, et al: Interme-

diate follow-up of pediatric heart transplant reci-

pients with elevated pulmonary vascular resistance

index. J Am Coll Cardiol 23:1682, 1994.

285. Fukushima N, Gundry SR, Razzouk AJ, Bailey LL:

Risk factors for graft failure associated with pulmo-

nary hypertension after pediatric heart transplanta-

tion. J Thorac Cardiovasc Surg 107:985, 1994.

286. Bailey LL: Heart transplantation techniques in

complex congenital heart disease. J Heart Lung

Transplant 12(6 Pt 2)S168, 1993.

287. Chartrand C, Guerin R, Kangah M, Stanley P:

Pediatric heart transplantation: Surgical considera-

tions for congenital heart diseases. J Heart Trans-

plant 9:608, 1990, discussion 616.

288. Zales VR, Wright KL, Pahl E, et al: Normal left ven-

tricular muscle mass and mass/volume ratio after

pediatric cardiac transplantation. Circulation 90(5

Pt 2)II61, 1994.

289. Canter CE, Moorhead S, Saffitz JE, et al: Steroid

withdrawal in the pediatric heart transplant reci-

pient initially treated with triple immunosuppres-

sion. J Heart Lung Transplant 12(1 Pt 1)74, 1994,

discussion, 79.

290. Boucek MM, Kanakriyeh MS, Mathis CM, et al:

Cardiac transplantation in infancy: Donors and

recipients. Loma Linda University Pediatric Heart

Transplant Group. J Pediatr 116:171, 1990.

291. Bridges ND, Malory GB Jr, Huddleston CB, et al:

Lung transplantation in children and young adults

with cardiovascular disease. Ann Thorac Surg

59:813, 1995, discussion 820.

292. Conte JV, Robbins RC, Reichenspurner H, et al:

Pediatric heart-lung transplantation: Intermediate-

term results. J Heart Lung Transplant 15:692, 1996.

293. Drews T, Stiller B, Hubler M, et al: Coagulation

management in pediatric mechanical circulatory

support. ASAIO J 53:640-645, 2007.

294. Wessel D: Managing low cardiac output syndrome

after congenital heart surgery. Crit Care Med

29:220-230, 2001.

295. Boucek MM, Edwards LB, Keck BM, et al: Registry

of the International Society for Heart and Lung

Transplantation: 8th official pediatric report—2005.

J Heart Lung Transplant 24:968-982, 2005.

296. Burke RP, Wernovsky G, van der Velde M, et al:

Video-assisted thoracoscopic surgery for congenital

heart disease. J Thorac Cardiovasc Surg 109:499,

1995, discussion 508.

297. Laborde F, Folliguet T, Batisse A, et al: Video-assis-

ted thoracoscopic surgical interruption: The techni-

que of choice for patent ductus arteriosus: Routine

experience in 230 pediatric cases. J Thorac Cardio-

vasc Surg 110:1681, 1995, discussion 1684.

298. Gould DS, Montenegro LM, Gaynor JW, et al: A

comparison of on-site and off-site patent ductus

arteriosus ligation in premature infants. Pediatrics

112:1298-1301, 2003.

299. DeSanctis RW, Doroghazi RM, AustenWG, Buckley

JJ: Aortic dissection. N Engl J Med 317:1060, 1987.

300. Mullins CE: Pediatric and congenital therapeutic

cardiac catheterization. Circulation 79:1153, 1989.

301. Malviya S, Burrows FA, Johnston AE, Benson LN:

Anaesthetic experience with paediatric interventio-

nal cardiology. Can J Anaesth 36:320, 1989.

302. Lock JE, Rome JJ, Davis R, et al: Transatrial closure

of atrial septal defects: Experimental studies. Circu-

lation 79:1091, 1989.

303. Hellenbrand WE, Fahey JT, McGowan FX, et al:

Transesophageal echocardiographic guidance for

transcatheter closure of atrial septal defects. Am J

Cardiol 66:207, 1990.

304. Hickey PR, Wessel DL, Streitz SL, et al: Transcathe-

ter closure of atrial septal defects: Hemodynamic

complications and anesthetic management. Anesth

Analg 74:44, 1992.

305. Masura J, Gavora P, Podnar T: Long-term outcome

of transcatheter secundum-type atrial septal defect

closure using Amplatzer septal occluders. J Am Coll

Cardiol 45:505-507, 2005.

306. Yew G, Wilson NJ: Transcatheter atrial septal defect

closure with the Amplatzer septal occluder: Five-

year follow-up. Cathet Cardiovasc Interv 64:193-

196, 2005.

307. Butera G, Carminati M, Chessa M, et al: Cardio-

SEAL/STARflex versus Amplatzer devices for per-

cutaneous closure of small to moderate (up to 18

mm) atrial septal defects. Am Heart J 148:507-510,

2004.

308. Amin Z, Hijazi ZM, Bass JL, et al: Erosion of

Amplatzer septal occluder device after closure

of secundum atrial septal defects: Review of registry

of complications and recommendations to mini-

mize future risk. Cathet Cardiovasc Interv 63:496-

502, 2004.

309. Suda K, Raboisson MJ, Piette E, et al: Reversible

atrioventricular block associated with closure of

atrial septal defects using the Amplatzer device.

J Am Coll Cardiol 43:1677-1682, 2004.

310. Krumsdorf U, Ostermayer S, Billinger K, et al: Inci-

dence and clinical course of thrombus formation on

atrial septal defect and patent foramen ovale closure

devices in 1000 consecutive patients. J Am Coll

Cardiol 43:302-309, 2004.

Anestesia para la cirugía cardíaca pediátrica

2417

73

Sección V

Anestesia pediátrica

© ELSEVIER. Fotocopiar sin autorización es un delito